These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9189764)

  • 1. Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells.
    Yu JS; Burwick JA; Dranoff G; Breakefield XO
    Hum Gene Ther; 1997 Jun; 8(9):1065-72. PubMed ID: 9189764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.
    Herrlinger U; Kramm CM; Johnston KM; Louis DN; Finkelstein D; Reznikoff G; Dranoff G; Breakefield XO; Yu JS
    Cancer Gene Ther; 1997; 4(6):345-52. PubMed ID: 9408604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
    Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
    Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
    Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
    J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.
    Herrlinger U; Aulwurm S; Strik H; Weit S; Naumann U; Weller M
    J Neurooncol; 2004 Jan; 66(1-2):147-54. PubMed ID: 15015780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF.
    Shi FS; Weber S; Gan J; Rakhmilevich AL; Mahvi DM
    Cancer Gene Ther; 1999; 6(1):81-8. PubMed ID: 10078967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.
    Wakimoto H; Abe J; Tsunoda R; Aoyagi M; Hirakawa K; Hamada H
    Cancer Res; 1996 Apr; 56(8):1828-33. PubMed ID: 8620500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
    Armstrong CA; Botella R; Galloway TH; Murray N; Kramp JM; Song IS; Ansel JC
    Cancer Res; 1996 May; 56(9):2191-8. PubMed ID: 8616871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model.
    Bonnekoh B; Greenhalgh DA; Chen SH; Block A; Rich SS; Krieg T; Woo SL; Roop DR
    J Invest Dermatol; 1998 Jun; 110(6):867-71. PubMed ID: 9620291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine.
    Mahvi DM; Burkholder JK; Turner J; Culp J; Malter JS; Sondel PM; Yang NS
    Hum Gene Ther; 1996 Aug; 7(13):1535-43. PubMed ID: 8864754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF.
    Qin H; Chatterjee SK
    Hum Gene Ther; 1996 Oct; 7(15):1853-60. PubMed ID: 8894677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.
    Sampson JH; Archer GE; Ashley DM; Fuchs HE; Hale LP; Dranoff G; Bigner DD
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10399-404. PubMed ID: 8816812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma.
    Smith KE; Janelidze S; Visse E; Badn W; Salford L; Siesjö P; Darabi A
    Int J Cancer; 2007 Jan; 120(1):75-80. PubMed ID: 17044023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel membrane-bound GM-CSF vaccines for the treatment of cancer: generation and evaluation of mbGM-CSF mouse B16F10 melanoma cell vaccine.
    Yei S; Bartholomew RM; Pezzoli P; Gutierrez A; Gouveia E; Bassett D; Soo Hoo W; Carlo DJ
    Gene Ther; 2002 Oct; 9(19):1302-11. PubMed ID: 12224013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of paracrine immunotherapy in experimental brain tumors.
    Lesniak MS; Sampath P; DiMeco F; Viglione MP; Tyler BM; Pardoll DM; Brem H
    Neurosurg Focus; 2000 Dec; 9(6):e4. PubMed ID: 16817687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J; Wu JH; Bouganim N; Galipeau J
    Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irradiated tumor cells adenovirally engineered to secrete granulocyte/macrophage-colony-stimulating factor establish antitumor immunity and eliminate pre-existing tumors in syngeneic mice.
    Nagai E; Ogawa T; Kielian T; Ikubo A; Suzuki T
    Cancer Immunol Immunother; 1998 Oct; 47(2):72-80. PubMed ID: 9769115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.
    Rakhmilevich AL; Imboden M; Hao Z; Macklin MD; Roberts T; Wright KM; Albertini MR; Yang NS; Sondel PM
    Clin Cancer Res; 2001 Apr; 7(4):952-61. PubMed ID: 11309346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
    Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.